The PDX model (Patient-Derived tumor Xenograft model) is a human-derived tumor xenograft model primarily constructed by transplanting fresh patient tumor tissue into immunodeficient mice (e.g., NCG). GemPharmatech offers a diverse collection of PDX models across multiple cancer types, along with PDX-based drug screening and pharmacodynamic efficacy analysis services.